Print Issue: June 01, 2008

Targeted Renal Therapy May Stop CIN

WASHINGTON, D.C.—Targeted renal therapy (TRT) involving intrarenal administration of fenoldopam is safe and feasible in patients undergoing angiographic procedures, even in patients at elevated risk of suffering from contrast-induced nephropathy (CIN).

Eyal Barzel, MD, implanting a dialysis catheter without the use of a sheath.

Success Placing Sheathless Catheters

WASHINGTON, D.C.—Tunneled dialysis catheters may be implanted without a sheath to limit the size of the venotomy and thus the potential for bleeding following catheter placement, according to a pilot study.

Restenosis Interventions Work Well

WASHINGTON, D.C.—Restenting and angioplasty are both highly effective for treating renal artery in-stent stenosis, according to findings presented here at the Society of Interventional Radiology’s 33rd Annual Scientific Meeting.

Next post in News